Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 151

Sort by

Sort Order Select

Journal Articles

Plasmin-mediated cleavage of high-molecular-weight kininogen contributes to acetaminophen-induced acute liver failure

Michael W. Henderson, Erica M. Sparkenbaugh, Shaobin Wang, Anton Ilich, Denis F. Noubouossie, Reiner Mailer, Thomas Renné, Matthew J. Flick, James P. Luyendyk, Zu-Lin Chen, Sidney Strickland, R. Todd Stravitz, Keith R. McCrae, Nigel S. Key, Rafal Pawlinski

Blood (2021) 138 (3): 259–272.

https://doi.org/10.1182/blood.2020006198

Published: 2021

Includes: Supplemental data

Journal Articles

Factor XIII cross-links fibrin(ogen) independent of fibrin polymerization in experimental acute liver injury

Lauren G. Poole, Anna K. Kopec, Dafna J. Groeneveld, Asmita Pant, Kevin S. Baker, Holly M. Cline-Fedewa, Matthew J. Flick, James P. Luyendyk

Blood (2021) 137 (18): 2520–2531.

https://doi.org/10.1182/blood.2020007415

Published: 2021

Includes: Supplemental data

Journal Articles

High Molecular Weight Kininogen but Not Factor XII Deficiency Attenuates Acetaminophen-Induced Liver Injury in Mice

Michael Wayne Henderson, MSc, Erica Sparkenbaugh, PhD BS, Denis Noubouossie, MD PhD, Reiner Mailer, Thomas Renne, MD PhD, Keith R McCrae, MD, Nigel S. Key, MBChB, FRCP, Rafal Pawlinski, PhD

Blood (2019) 134 (Supplement_1): 3621.

https://doi.org/10.1182/blood-2019-127206

Published: 2019

Journal Articles

Prevention and Management of Daratumumab Mediated Infusion Related Hypersensitivity Reactions Pre-and Post-Implementation of Rapid Infusion Protocol

My L Nguyen, PharmD, Catherine Burdalski, PharmD, BCOP, Syed Abbas Ali, MD, Lindsay Kohler, BS, PharmD Candidate, Steven Gilmore, PharmD, BCOP

Blood (2019) 134 (Supplement_1): 5811.

https://doi.org/10.1182/blood-2019-125391

Published: 2019

Journal Articles

Single Arm, Prospective, Open-Label Phase II Trial to Evaluate the Efficacy of Isatuximab in Patients with Monoclonal Gammopathy of Renal Significance

Vikram Premkumar, MD, Suzanne Lentzsch, MD PhD, Divaya Bhutani, MD

Blood (2019) 134 (Supplement_1): 3161.

https://doi.org/10.1182/blood-2019-123496

Published: 2019

Journal Articles

Characteristics and Outcomes of Ibrutinib-Associated Musculoskeletal Toxicities in CLL Patients

Joanna Rhodes, MD, Anthony R. Mato, MD MSCE, Nicole Winchell, Kaitlin Kennard, RN, BSN, James Nathan Gerson, MD, Daniel J. Landsburg, MD, Sunita Dwivedy Nasta, MD, Jakub Svoboda, MD, Stephen J. Schuster, MD

Blood (2018) 132 (Supplement 1): 4418.

https://doi.org/10.1182/blood-2018-99-115377

Published: 2018

Journal Articles

Opioid Prescribing Habits in Sickle Cell Disease: An International Survey of Providers

Nadirah El-Amin, MPH, DO, Paul Nietert, PhD, Julie Kanter, MD

Blood (2018) 132 (Supplement 1): 2371.

https://doi.org/10.1182/blood-2018-99-117206

Published: 2018

Journal Articles

Ten New Cases of Hermansky-Pudlak Syndrome in the Iberian Peninsula: Identification of Novel Genetic Variants in HPS3, HPS4, HPS6 and DTNBP1 Associated with Significant Clinical Complications

Blood (2018) 132 (Supplement 1): 1147.

https://doi.org/10.1182/blood-2018-99-112968

Published: 2018

Journal Articles

Inflammation and Tissue Damage Mediated By PAR-1 Expression Is Cell Type-Specific and Varies Depending on the Inflammatory Challenge

Alexander A Boucher, MD, Leah A. Rosenfeldt, BS, Duaa Mureb, BS, Anna K Kopec, PhD, James P. Luyendyk, PhD, Matthew J. Flick, PhD, Joseph S. Palumbo, MD

Blood (2018) 132 (Supplement 1): 133.

https://doi.org/10.1182/blood-2018-99-117312

Published: 2018

Journal Articles

Evaluation of the Safety and Tolerability of Rapid Infusion of Biosimilar Rituximab Truxima® — the University College London Hospitals (UCLH) Experience

Raakhee Shah, MPharm, Simon Cheesman, BPharm, Kirit M Ardeshna, MD, Kate Cwynarski, MD, David C. Linch, FRCP, Andres E. Virchis, FRCP, FRCPath, Jonathan Richard Lambert, Christopher Mcnamara, William Townsend

Blood (2017) 130 (Supplement 1): 3387.

https://doi.org/10.1182/blood.V130.Suppl_1.3387.3387

Published: 2017

Journal Articles

Prevention of Morbidity in Sickle Cell Disease Phase II (Improvement of Cognition in children with Sickle Cell Disease with Auto-adjusting Continuous Positive Airways Pressure: Phase II) (POMS 2b paediatric cohort)

April E Slee, Jamie M Kawadler, PhD, Melanie Koelbel, MSc, Hanne Stotesbury, MSc, David C Rees, MD, Maria Pelidis, MD, Jo Howard, MBBCh, Swee Lay Thein, DSc,FRCP,FRCPath,MBBS,MRCPath,MRCP, Simon Skene, PhD, Sahota Sati, BSc, Carol Nwosu, BSc, Maureen Gwam, BSc, Dawn Saunders, MD, Johanna C Gavlak, PhD, Gupta Atul, MD, Simrat Sarkaria, Christina Liossi, PhD, Fenella J Kirkham, MD, Baba Inusa, MD MRCP

Blood (2017) 130 (Supplement 1): 3556.

https://doi.org/10.1182/blood.V130.Suppl_1.3556.3556

Published: 2017

Journal Articles

Risk Factors for Thrombosis in the Neonatal Intensive Care Unit: Analysis of a Large National Database

Uttara Nag, MD, Greenberg Rachel, MD MHS, Harold J Leraas, BS, MA, Candice Roberts, MD, Reed Kamyszek, BS, Elisabeth Tracy, MD

Blood (2017) 130 (Supplement 1): 3351.

https://doi.org/10.1182/blood.V130.Suppl_1.3351.3351

Published: 2017

Journal Articles

Prevention of Morbidity in Sickle Cell Disease Phase II (Improvement of Pain and Quality of Life in Children with Sickle Cell Disease with Auto-adjusting Continuous Positive Airways Pressure: Phase II) (POMS 2b pediatric cohort)

Baba Inusa, MD MRCP, Jo Howard, MBBCh, Subarna Chakravorty, MBBS, PhD FRCPath, MRCP, Maria Pelidis, MD, Swee Lay Thein, DSc,FRCP,FRCPath,MBBS,MRCPath,MRCP, Fenella J Kirkham, MD

Blood (2017) 130 (Supplement 1): 3537.

https://doi.org/10.1182/blood.V130.Suppl_1.3537.3537

Published: 2017

Journal Articles

Monoclonal Antibody Utilization Characteritics in Patients with Multiple Myeloma

Sikander Ailawadhi, Abdel-Ghani Azzouqa, Zahara Meghji, Tania Jain, MD, Nancy Diehl, Stephanie P. Gebhardt, Vishal Shah, David O. Hodge, MS, Raj Patel, MD, Prachi Jani, MD, Taimur Sher, MD, Vivek Roy, MD, Meghna Ailawadhi, MD, Victoria R. Alegria, Aneel Paulus, MD, Asher A. Chanan-Khan, MD, Rafael Fonseca, MD

Blood (2017) 130 (Supplement 1): 5440.

https://doi.org/10.1182/blood.V130.Suppl_1.5440.5440

Published: 2017

Journal Articles

Use of Premedication Prior to Asparaginase (ASNase) Administration in Pediatric Acute Lymphoblastic Leukemia (ALL): Effect on Treatment Completion Rate

Celine Bernard, MBA, Nathan Rustay, PhD, Kira Mamedov, MD

Blood (2017) 130 (Supplement 1): 5574.

https://doi.org/10.1182/blood.V130.Suppl_1.5574.5574

Published: 2017

Journal Articles

Morbidity Pattern in Sickle Cell Disease in Central Gujarat, India — Single Centre Perspective

Seema S. Bhatwadekar, MD, Shubhangi Vishwas Deshpande, MDMDcine, Shweta Vikas Khadse, BHMS, Bijal Shah, MBBS,DCP, Devenkumar Desai, MBBS DCP

Blood (2017) 130 (Supplement 1): 4785.

https://doi.org/10.1182/blood.V130.Suppl_1.4785.4785

Published: 2017

Journal Articles

Home Administration of Subcutaneous Rituximab Is Safe and Associated with Significant Cost Saving: A Single Center Experience

Alice Wolfromm, MD, Benedicte Mittaine, MD, Nicolas Gandrille, MD, Julie Dallemagne, MD, Richard Delarue, MD

Blood (2017) 130 (Supplement 1): 4676.

https://doi.org/10.1182/blood.V130.Suppl_1.4676.4676

Published: 2017

Journal Articles

Interpretation of TEG Studies in Management of a Severe Glanzmann Thrombasthenia Patient

Paulette Bryant, MD, Katie Andricopulos, PharmD, BCPPS

Blood (2017) 130 (Supplement 1): 4854.

https://doi.org/10.1182/blood.V130.Suppl_1.4854.4854

Published: 2017

Journal Articles

Alemtuzumab for Treatment-Naïve and Relapsed-Refractory Severe Acquired Aplastic Anemia

Nayara Ribeiro Guedes, Juliana Goncalves, MD, Marcelo Lacerda, MD, Maria Cristina Nunez, ANA RITA F B Medeiros, MD, Ana Carolina Kirchmeyer, Andre domingues Pereira, MD, Patricia Eiko Yamakawa, MD, Melca Oliveira Barros, MD PhD, Matheus Vescovi, MD PhD, Mihoko Yamamoto, MD PhD, Celso Arrais, MD PhD

Blood (2017) 130 (Supplement 1): 4961.

https://doi.org/10.1182/blood.V130.Suppl_1.4961.4961

Published: 2017

Journal Articles

Daratumumab Monotherapy in Thirty-Two Heavily Pre-Treated Patients with Advanced Systemic Light-Chain Amyloidosis

Christoph Kimmich, MD, Stefan Schönland, MD, Rita Ziehl, Anthony D. Ho, Tobias Dittrich, MD, Carsten Müller-Tidow, Ute Hegenbart

Blood (2017) 130 (Supplement 1): 1837.

https://doi.org/10.1182/blood.V130.Suppl_1.1837.1837

Published: 2017

NARROW

Plasmin-mediated cleavage of high-molecular-weight kininogen contributes to acetaminophen-induced acute liver failure

Factor XIII cross-links fibrin(ogen) independent of fibrin polymerization in experimental acute liver injury

High Molecular Weight Kininogen but Not Factor XII Deficiency Attenuates Acetaminophen-Induced Liver Injury in Mice

Prevention and Management of Daratumumab Mediated Infusion Related Hypersensitivity Reactions Pre-and Post-Implementation of Rapid Infusion Protocol

Single Arm, Prospective, Open-Label Phase II Trial to Evaluate the Efficacy of Isatuximab in Patients with Monoclonal Gammopathy of Renal Significance

Characteristics and Outcomes of Ibrutinib-Associated Musculoskeletal Toxicities in CLL Patients

Opioid Prescribing Habits in Sickle Cell Disease: An International Survey of Providers

Ten New Cases of Hermansky-Pudlak Syndrome in the Iberian Peninsula: Identification of Novel Genetic Variants in HPS3, HPS4, HPS6 and DTNBP1 Associated with Significant Clinical Complications

Inflammation and Tissue Damage Mediated By PAR-1 Expression Is Cell Type-Specific and Varies Depending on the Inflammatory Challenge

Evaluation of the Safety and Tolerability of Rapid Infusion of Biosimilar Rituximab Truxima® — the University College London Hospitals (UCLH) Experience

Prevention of Morbidity in Sickle Cell Disease Phase II (Improvement of Cognition in children with Sickle Cell Disease with Auto-adjusting Continuous Positive Airways Pressure: Phase II) (POMS 2b paediatric cohort)

Risk Factors for Thrombosis in the Neonatal Intensive Care Unit: Analysis of a Large National Database

Prevention of Morbidity in Sickle Cell Disease Phase II (Improvement of Pain and Quality of Life in Children with Sickle Cell Disease with Auto-adjusting Continuous Positive Airways Pressure: Phase II) (POMS 2b pediatric cohort)

Monoclonal Antibody Utilization Characteritics in Patients with Multiple Myeloma

Use of Premedication Prior to Asparaginase (ASNase) Administration in Pediatric Acute Lymphoblastic Leukemia (ALL): Effect on Treatment Completion Rate

Morbidity Pattern in Sickle Cell Disease in Central Gujarat, India — Single Centre Perspective

Home Administration of Subcutaneous Rituximab Is Safe and Associated with Significant Cost Saving: A Single Center Experience

Interpretation of TEG Studies in Management of a Severe Glanzmann Thrombasthenia Patient

Alemtuzumab for Treatment-Naïve and Relapsed-Refractory Severe Acquired Aplastic Anemia

Daratumumab Monotherapy in Thirty-Two Heavily Pre-Treated Patients with Advanced Systemic Light-Chain Amyloidosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only